Veracyte CFO sells 3,561 shares under 10b5-1 plan

Veracyte, Inc. Chief Financial Officer Rebecca Chambers reported recent transactions in the company’s common stock.

Rhea-AI Filing Summary

Veracyte, Inc. Chief Financial Officer Rebecca Chambers reported recent transactions in the company’s common stock. On June 4, 2026, she executed two open-market sales totaling 3,561 shares at weighted average prices of $49.2836 and $50.0913 per share, under a pre-arranged Rule 10b5-1 trading plan adopted on August 21, 2025.

Separately, on June 2, 2026, 3,693 shares were withheld to cover tax obligations upon the vesting of restricted stock units; this was not an open-market sale. After these transactions, Chambers directly holds 173,280 shares of Veracyte common stock.

Insider Trade Summary 10b5-1

Net Seller: 3,561 shares

Net Sell 3 txns

Insider Chambers Rebecca

Role Chief Financial Officer

Sold 3,561 shs ($177K)

Type	Security	Shares	Price	Value
Sale	Common Stock	1,600	$49.2836	$79K
Sale	Common Stock	1,961	$50.0913	$98K
Exercise Price or Tax Liability	Common Stock	3,693	$47.80	$177K

Holdings After Transaction: Common Stock — 173,280 shares (Direct)

Footnotes (4)

1. F1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.
2. F2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.
3. F3. Represents weighted average sales price. Sale prices for the transactions range from $48.80 to $49.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.
4. F4. Represents weighted average sales price. Sale prices for the transactions range from $49.88 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Key Figures

Open-market sale 1: 1,961 shares at $50.0913 Open-market sale 2: 1,600 shares at $49.2836 Total shares sold: 3,561 shares +2 more

5 metrics

Open-market sale 1 1,961 shares at $50.0913 Common Stock sale on June 4, 2026

Open-market sale 2 1,600 shares at $49.2836 Common Stock sale on June 4, 2026

Total shares sold 3,561 shares Net open-market sales reported in Form 4

Tax withholding shares 3,693 shares at $47.80 Withheld for RSU tax obligations on June 2, 2026

Post-transaction holdings 173,280 shares Direct ownership after reported transactions

Key Terms

Rule 10b5-1 plan, restricted stock units, weighted average sales price

3 terms

Rule 10b5-1 plan financial

"The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025."

A Rule 10b5-1 plan is a prearranged, written schedule that lets corporate insiders buy or sell company stock at set times or amounts, even if they later learn material nonpublic information. Think of it like setting an automatic thermostat for trades: it creates a clear record that trades were planned in advance, reducing the risk of insider-trading accusations and helping investors trust that insider transactions are routine rather than based on secret information.

restricted stock units financial

"tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

weighted average sales price financial

"Represents weighted average sales price. Sale prices for the transactions range from $48.80 to $49.74."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Veracyte (VCYT) CFO Rebecca Chambers report?

Rebecca Chambers reported two open-market sales totaling 3,561 Veracyte shares on June 4, 2026, plus 3,693 shares withheld on June 2, 2026 for tax obligations related to restricted stock unit vesting, which the company clarifies did not constitute an open-market sale.

At what prices did the Veracyte (VCYT) CFO sell her shares?

On June 4, 2026, the CFO sold 1,600 Veracyte shares at a weighted average price of $49.2836 and 1,961 shares at a weighted average price of $50.0913, with detailed price ranges available to regulators, the issuer, or shareholders upon request.

How many Veracyte (VCYT) shares does the CFO hold after these transactions?

Following the reported transactions, Veracyte’s CFO directly holds 173,280 shares of common stock. This figure reflects the impact of the June 2, 2026 tax-withholding share disposition and the June 4, 2026 open-market sales reported in the Form 4 filing.

Were the Veracyte (VCYT) CFO’s stock sales made under a Rule 10b5-1 plan?

Yes. The Form 4 notes that the reported transactions were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 21, 2025, indicating the sales were pre-arranged rather than timed on an ad hoc basis.

Did the Veracyte (VCYT) CFO’s tax-related share disposition represent an actual stock sale?

No. The 3,693 Veracyte shares on June 2, 2026 were withheld to satisfy the CFO’s tax withholding obligations upon vesting of restricted stock units. The filing specifies this withholding does not represent a market sale of shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/04/2026 - 09:38 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Chambers Rebecca

(Last) (First) (Middle)

6000 SHORELINE COURT

SUITE 300

(Street)

SOUTH SAN FRANCISCO CALIFORNIA 94080

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
VERACYTE, INC. [ VCYT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Financial Officer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/02/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/02/2026		F(1)		3,693	D	$47.8	176,841	D
Common Stock	06/04/2026		S(2)		1,600	D	$49.2836(3)	175,241	D
Common Stock	06/04/2026		S(2)		1,961	D	$50.0913(4)	173,280	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Represents shares of common stock withheld to satisfy the Reporting Person's tax withholding obligations in connection with the vesting of certain restricted stock units on June 2, 2026 and does not represent a sale.

2. The transactions on this Form 4 were made pursuant to a Rule 10b5-1 plan adopted by the reporting person on August 21, 2025.

3. Represents weighted average sales price. Sale prices for the transactions range from $48.80 to $49.74. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

4. Represents weighted average sales price. Sale prices for the transactions range from $49.88 to $50.40. Detailed information regarding the number of shares sold at each separate price will be provided to the SEC, the issuer or a shareholder upon request.

Remarks:

	/s/ Jonathan Wygant as attorney-in-fact	06/04/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)